Patent details

301387 Product Name: Aumolertinib of een farmaceutisch aanvaardbaar zout daarvan, in het bijzonder aumolertinib mesilaat

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301387
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3205650
Status:
Application Pending
Application number:
301387
Procedural language:
Dutch
First Applicant Residence Country:
China (CN)

Marketing Authorization

Marketing Authorization Number:
EU/1/25/2006
Marketing Authorization Type:
EEA
Marketing Authorization Date:
13/02/2026
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
11/06/2026
First Marketing Authorization date:
13/02/2026
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
12/06/2026
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
11/06/2026
 
 

 

Name:
SHANGHAI HANSOH BIOMEDICAL CO., LTD.
Address:
Building 2, No.3728 Jinke Road Zhangjiang Hi-Tech Park, 201203, SHANGHAI, China (CN)

From:
11/06/2026
 
 

 

Name:
JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD
Address:
The 10th Industrial Sub-zone Of Development Zone Lianyungang, 222047, JIANGSU, China (CN)

Agent

Name:
ir. J.C. Volmer c.s.
From:
11/06/2026
Address:
Exter Polak & Charlouis B.V. Postbus 3241, 2280 GE, Rijswijk, Netherlands (NL)
To:

Publication

Bulletin

Bulletin Heading:
SPC
Journal edition number:
24/26
Publication date:
17/06/2026
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
12/06/2026 Outgoing Correspondence Confirmation receipt request 2 PDF /3/4/3/7/5/0801257343/docs/301387_8_301387712837l174.pdf
11/06/2026 SPC Documents Annex SPC 253 PDF /3/4/3/7/5/0801257343/docs/301387_0_supplprotectioncertificate20260612091546026.pdf
11/06/2026 SPC Documents Annex SPC 14 PDF /3/4/3/7/5/0801257343/docs/301387_1_supplprotectioncertificate20260612091845098.pdf
11/06/2026 SPC Documents Annex SPC 1 PDF /3/4/3/7/5/0801257343/docs/301387_2_supplprotectioncertificate20260612092011393.pdf
11/06/2026 SPC Documents Annex SPC 11 PDF /3/4/3/7/5/0801257343/docs/301387_3_supplprotectioncertificate20260612091329562.pdf
11/06/2026 SPC Documents Summary of the characteristics of the product 23 PDF /3/4/3/7/5/0801257343/docs/301387_4_supplprotectioncertificate20260612091845062.pdf
11/06/2026 SPC Documents Annex SPC 2 PDF /3/4/3/7/5/0801257343/docs/301387_5_supplprotectioncertificate20260612091845089.pdf
11/06/2026 SPC Documents Marketing Authorization SPC 3 PDF /3/4/3/7/5/0801257343/docs/301387_6_supplprotectioncertificate20260612091919968.pdf
11/06/2026 SPC Documents Accompanying letter SPC 3 PDF /3/4/3/7/5/0801257343/docs/301387_7_supplprotectioncertificate20260612092114519.pdf
11/06/2026 Application Form First filed application form 2 PDF /3/4/3/7/5/0801257343/docs/301387_9_applicationform20260612090759170.pdf